Earnings Play Canopy Growth Corporation
Cannabis stocks got a boost after 5 states legalized marijuana.
Share this:
On Monday, before market, Canopy Growth Corporation (CGC) is anticipated to release third quarter revenue of approximately $119.1 million vs. $76.6 million last year. The company cultivates and sells medicinal and recreational cannabis, and on November 4th, ABC News reported that 5 states passed marijuana legalization measures.
Looking at a daily chart, in logarithmic scale, Canopy's stock price has been in a short-term uptrend since the beginning of October. The RSI is bullish and currently just below overbought territory. The simple moving averages (SMA) have just turned bullish, as the 20-day SMA is above the 50-day SMA, and the 50-day SMA is above the 200-day SMA. On the chart traders can see that after the election on November 3rd Canopy's stock price became very volatile and has gapped at each market open since. Price will likely continue to rise towards the 2020 high of $26.00. At around $26.00 the stock will probably sell off a bit as speculators take some profits, and price will likely pull back to the 20-day SMA around the bullish trendline. If price can manage to hold above the bullish trendline then it could be a chance for late comers to jump on for a retest of $26.00. If price breaks out to the upside of 26.00, then its next targets would be $29.60 and 34.30, levels last reached in 2019. On the flip side, if Canopy pulls back to the bullish trendline and breaks below it, then a rebound could occur at around 17.40. If price cant hold at 17.40 then it could dip to 15.50, which would be a bearish signal as price be below the 200-day SMA. If price cant find footing on 15.50, then it will likely decline further to 13.80.
Source: GAIN Capital, TradingView
Looking at a daily chart, in logarithmic scale, Canopy's stock price has been in a short-term uptrend since the beginning of October. The RSI is bullish and currently just below overbought territory. The simple moving averages (SMA) have just turned bullish, as the 20-day SMA is above the 50-day SMA, and the 50-day SMA is above the 200-day SMA. On the chart traders can see that after the election on November 3rd Canopy's stock price became very volatile and has gapped at each market open since. Price will likely continue to rise towards the 2020 high of $26.00. At around $26.00 the stock will probably sell off a bit as speculators take some profits, and price will likely pull back to the 20-day SMA around the bullish trendline. If price can manage to hold above the bullish trendline then it could be a chance for late comers to jump on for a retest of $26.00. If price breaks out to the upside of 26.00, then its next targets would be $29.60 and 34.30, levels last reached in 2019. On the flip side, if Canopy pulls back to the bullish trendline and breaks below it, then a rebound could occur at around 17.40. If price cant hold at 17.40 then it could dip to 15.50, which would be a bearish signal as price be below the 200-day SMA. If price cant find footing on 15.50, then it will likely decline further to 13.80.
Source: GAIN Capital, TradingView
On Monday, before market, Canopy Growth Corporation (CGC) is anticipated to release third quarter revenue of approximately $119.1 million vs. $76.6 million last year. The company cultivates and sells medicinal and recreational cannabis, and on November 4th, ABC News reported that 5 states passed marijuana legalization measures.
Looking at a daily chart, in logarithmic scale, Canopy's stock price has been in a short-term uptrend since the beginning of October. The RSI is bullish and currently just below overbought territory. The simple moving averages (SMA) have just turned bullish, as the 20-day SMA is above the 50-day SMA, and the 50-day SMA is above the 200-day SMA. On the chart traders can see that after the election on November 3rd Canopy's stock price became very volatile and has gapped at each market open since. Price will likely continue to rise towards the 2020 high of $26.00. At around $26.00 the stock will probably sell off a bit as speculators take some profits, and price will likely pull back to the 20-day SMA around the bullish trendline. If price can manage to hold above the bullish trendline then it could be a chance for late comers to jump on for a retest of $26.00. If price breaks out to the upside of 26.00, then its next targets would be $29.60 and 34.30, levels last reached in 2019. On the flip side, if Canopy pulls back to the bullish trendline and breaks below it, then a rebound could occur at around 17.40. If price cant hold at 17.40 then it could dip to 15.50, which would be a bearish signal as price be below the 200-day SMA. If price cant find footing on 15.50, then it will likely decline further to 13.80.
Source: GAIN Capital, TradingView
Looking at a daily chart, in logarithmic scale, Canopy's stock price has been in a short-term uptrend since the beginning of October. The RSI is bullish and currently just below overbought territory. The simple moving averages (SMA) have just turned bullish, as the 20-day SMA is above the 50-day SMA, and the 50-day SMA is above the 200-day SMA. On the chart traders can see that after the election on November 3rd Canopy's stock price became very volatile and has gapped at each market open since. Price will likely continue to rise towards the 2020 high of $26.00. At around $26.00 the stock will probably sell off a bit as speculators take some profits, and price will likely pull back to the 20-day SMA around the bullish trendline. If price can manage to hold above the bullish trendline then it could be a chance for late comers to jump on for a retest of $26.00. If price breaks out to the upside of 26.00, then its next targets would be $29.60 and 34.30, levels last reached in 2019. On the flip side, if Canopy pulls back to the bullish trendline and breaks below it, then a rebound could occur at around 17.40. If price cant hold at 17.40 then it could dip to 15.50, which would be a bearish signal as price be below the 200-day SMA. If price cant find footing on 15.50, then it will likely decline further to 13.80.
Source: GAIN Capital, TradingView
Related tags:
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
EUR/USD Q4 2026 Outlook: Euro at a Crossroads as Fed, ECB Tighten 9 25 2026
EUR/USD enters Q4 at a pivotal inflection point as competing Fed-ECB policy paths and persistent inflation risks collide with major technical support.
USD/JPY Q4 2026 Outlook: Hawkish Fed Pricing Clashes With Intervention Risk
The year-end tug-of-war is clear: hawkish Fed pricing supports USD/JPY, while intervention risk limits the upside.
Japanese Yen Forecast: USD/JPY 4% Rally Challenges Post-Intervention Downtrend 9 24 2026
USD/JPY momentum has shifted sharply higher, putting a major resistance confluence in focus as U.S. and Japanese event risk builds.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.